WisdomTree U.S. SmallCap Fund (NYSEARCA:EES) Stock Price Down 2.5%

Share on StockTwits

WisdomTree U.S. SmallCap Fund (NYSEARCA:EES)’s share price traded down 2.5% during mid-day trading on Friday . The stock traded as low as $33.01 and last traded at $33.01, 300 shares changed hands during trading. A decline of 100% from the average session volume of 88,566 shares. The stock had previously closed at $33.85.

The company’s 50 day moving average is $34.87 and its 200-day moving average is $35.99.

Institutional investors have recently added to or reduced their stakes in the stock. FMR LLC increased its stake in WisdomTree U.S. SmallCap Fund by 9,425.0% during the 1st quarter. FMR LLC now owns 762 shares of the company’s stock worth $27,000 after buying an additional 754 shares during the period. Signaturefd LLC purchased a new stake in WisdomTree U.S. SmallCap Fund during the 2nd quarter worth $28,000. Brand Asset Management Group Inc. purchased a new stake in WisdomTree U.S. SmallCap Fund during the 2nd quarter worth $42,000. Meridian Wealth Management LLC purchased a new stake in WisdomTree U.S. SmallCap Fund during the 1st quarter worth $51,000. Finally, Steward Partners Investment Advisory LLC purchased a new stake in WisdomTree U.S. SmallCap Fund during the 2nd quarter worth $60,000.

WisdomTree U.S. SmallCap Fund Company Profile (NYSEARCA:EES)

WisdomTree SmallCap Earnings Fund (the Fund) seeks investment results that correspond to the price and yield performance of the WisdomTree SmallCap Earnings Index (the Index). The Index is a fundamentally weighted index that measures the performance of earnings-generating companies within the small-capitalization segment of the United States stock market.

Read More: Why investors pay attention to retained earnings

Receive News & Ratings for WisdomTree U.S. SmallCap Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree U.S. SmallCap Fund and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell
Playa Hotels & Resorts  Upgraded at Zacks Investment Research
Playa Hotels & Resorts Upgraded at Zacks Investment Research


 
© 2006-2019 Zolmax.